FROVA®
In January 2008 Teva Neuroscience Canada launched FROVA® (frovatriptan succinate tablets), a unique treatment for patients suffering from migraines. FROVA® is indicated for the acute treatment of migraine attacks with or without aura in adults. The launch of FROVA® in Canada is further proof of Teva Neuroscience’s commitment to patients suffering from neurology disorders. If you have any questions regarding your migraine therapy, we recommend that you direct them to your physician, pharmacist, nurse or other health care professional.
Call our toll-free Customer Service line at 1-866-530-6065.
Learn more about FROVA® in our product monograph.
A unique treatment that provides lasting relief for migraines of long duration. For additional support and information, visit Frova.ca.